https://www.selleckchem.com/
9%). Mortality within 30 days was 2%, the median duration of intensive care unit stay was one day and the median hospital length of stay was 8 days. One patient needed reoperation later for recurrent mitral regurgitation. Five and ten year MACCE-free survival was 91.1% (95%-CI 85.3-97.2) and 81.0 (95%-CI 71.6-91.6), respectively. Five year survival was 93.5% (95-CI 88.6-98.7) and 10 year survival 85.3% (95%-CI 76.6-94.9), which was not different from an age and gender matched reference population (p=0.135, log-rank test). Outcomes of mitral valve repair due